Skip to main content
SpringerLink
Log in

Neue Entwicklungen und Tendenzen in der Pharmakotherapie chronisch entzündlicher Darmerkrankungen

  • Conference paper
94. Kongreß

Part of the book series: Verhandlungen der Deutschen Gesellschaft für Innere Medizin ((VDGINNERE,volume 94))

  • 29 Accesses

Zusammenfassung

Das Ziel, die chronisch entzündliche Darmerkrankungen durch Medikamente zu heilen, wurde bislang nicht erreicht. Es hat dabei nicht an Versuchen und Untersuchungen gefehlt. In Anbetracht der nach wie vor ungeklärten Pathogenese ist man verschiedenen Spuren gefolgt, aber keine führte zum Ziel.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 44.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 59.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Allison MC, Pounder RE (1984) Cyclosporin for Crohn’s disease. Lancet I:902–903

    Article  Google Scholar 

  2. Allison MC, Pounder RE (1987) Cyclosporin for Crohn’s disease. Aliment Pharmacol Ther 1:39–43

    Article  PubMed  CAS  Google Scholar 

  3. Azad Khan AK, Piris J, Truelove SC (1977) An experiment to determine the active therapeutic moiety of sulphasalazine. Lancet II: 892–895

    Google Scholar 

  4. Bansky G, Bühler H, Stamm B, et al. (1987) Treatment of distal ulcertive colitis with beclomethasone enemas: high therapeutic efficacy without endocrine side effects. A prospective, randomized double-blind trial. Dis Colon Rectum 30:288–292

    Article  PubMed  CAS  Google Scholar 

  5. Binder V, Eisborg L, Griebe J, et al. (1981) Disodium cromoglycate in the treatment of ulcerative colitis and Crohn’s disease. Gut 22:55–60

    Article  PubMed  CAS  Google Scholar 

  6. Burnham WR, Lennard-Jones JE, Hecketsweiler P, et al. (1979) Oral BCG vaccine in Crohn’s disease. Gut 20:229–233

    Article  PubMed  CAS  Google Scholar 

  7. Campbell DES (1986) Therapie der Colitis ulcerosa auf der Basis von 5-Aminosalizylsäure. Schwerpunktmed 9:12–20

    Google Scholar 

  8. Campieri M, Lanfranchi GA, Bazzocchi G, et al. (1981) Treatment of ulcerative colitis with high dose 5- aminosalicylic acid enemas. Lancet II: 270–271

    Article  Google Scholar 

  9. Campieri M, Lanfranchi GA, Bertoni F, et al. (1984) A doubleblind clinical trial to compare the effects of 4-aminosalicylic acid in topical treatment of ulcerative colitis. Digestion 29:204–208

    Article  PubMed  CAS  Google Scholar 

  10. Camperi M, Lanfranchi GA, Bazzocchi G, et al. (1980) Prostaglandins, indomethacine and ulcerative colitis. Gastroenterology 78:193 (letter)

    Google Scholar 

  11. Dickinson RJ, O’Connor JH, Pinder I, et al. (1985) Double blind controlled trial of oral vancomycin as adjunctive treatment in acute exacerbations of idiopathic colitis. Gut 26:1380–1384

    Article  PubMed  CAS  Google Scholar 

  12. Dronfield MW, Lang MJS (1978) Comparative trial of sulphasalazine and oral sodium cromoglycate in the maintenance of remission in ulcerative colitis. Gut 19:1136–1139

    Article  PubMed  CAS  Google Scholar 

  13. Dronfield MW, Malone JDG, Langman MJS (1977) Zinc in ulcerative colitis: A therapeutic trial and report on plasma levels. Gut 18:33–36

    Article  PubMed  CAS  Google Scholar 

  14. Ewe K, Eckardt V, Kanzler G (1988) Treatment of ulcerative colitis with sodium azodisalicylate and sulfasalazine: Effectiveness and side effects. Scand J Gastroenterol (im Druck)

    Google Scholar 

  15. Ferency P, Lochs H, Poetzi R, Dragosics B (1982) Longterm treatment of Crohn’s disease with dapsone — a controlled study. Gastroenterology 82:1054 (abstract)

    Google Scholar 

  16. Gandolfo J, Farthing M, Powers G, et al. (1987) 4-aminosalicylic acid retention enemas in treatment of distal colitis. Dig Dis Sci 32:700–704

    Article  PubMed  CAS  Google Scholar 

  17. Ginsberg AL, Beck LS, Mcintosh TM, Nochomovitz LE (1987) Placebo controlled trial of 4-aminosalicylic acid enemas in leftsided ulcerative colitis. Gastroenterology 92:1406 (abstract)

    Google Scholar 

  18. Goerg KJ, Wanitschke R, Diehl PH, Meyer zum Büschenfelde KH (1988) Secretory effect of azodisalicylate (azodisal sodium) on the short circuited mucosa of the rat ileum in vitro. Gut 29:336–341

    Article  PubMed  CAS  Google Scholar 

  19. Goldman E, Rachmilewitz D (1983) Prostanoids cytoprotection for maintaining remission in ulcerative colitis. Failure of 15(R), 15-methylprostaglandin E2. Dig Dis Sci 28:807–811

    Article  Google Scholar 

  20. Gupta S, Keshavarzian A, Hodgson HJF (1984) Cyclosporin in ulcerative colitis. Lancet II:1277–1278

    Article  Google Scholar 

  21. Hamilton MB, Pinder IF, Dickinsen RJ, et al. (1984) A comparison of prednisolone enemas with low dose oral prednisolone in the treatment of acute distal ulcerative colitis. Dis Colon Rectum 27:701–702

    Article  PubMed  CAS  Google Scholar 

  22. Hanauer SB, Kirsner JB, Barret WE (1986) The treatment of leftsided ulcerative colitis with tixocortol pivalate (TP). Gastroenterology 90 (part 2): 1520 (abstract)

    Google Scholar 

  23. Harris DM (1975) Properties and therapeutic uses of some corticosteroids with enhenced topical potency. J Steroid Biochem 6:711–716

    Article  PubMed  CAS  Google Scholar 

  24. Hartmann F (1986) 5-Aminosalicylsäure — neue Therapiemöglichkeit bei chronisch entzündlicher Darmerkrankung? Leber Magen Darm 16:20–27

    PubMed  CAS  Google Scholar 

  25. Hermanowitz A, Nowak A, Gajos L (1984) Controlled therapeutic trials of levamisole and sulphasalzine in acute ulcerative colitis. Gut 25:534–538

    Article  Google Scholar 

  26. von der Heide H, Mulder CJJ, Wiltink EHH, et al. (1987) Comparison of enemas containing beclomethasone di-proprionate (BDP) or prednisolone-21-phosphate (PP) in the treatment of distal ulcerative colitis. Gastroenterology 92:1679 (abstract)

    Google Scholar 

  27. Kumana CR, Seaton T, Meghji M, et al. (1982) Beclomethasone diproprionate enemas for treating inflammatory bowel disease without producing Cushing’s syndrome or hypothalamic pituitary adrenal supression. Lancet I:579–583

    Article  Google Scholar 

  28. la Rochelle P, du Sonich P, Bolte E, Lebrier J, Goyer R (1983) Tixocortol pivalate, cortisosteroid with no systemic glucocorticoid effect after oral, intratecal, and intranasal application. Clin Pharmacol Ther 33:343–350

    Article  Google Scholar 

  29. Lee DAH, Taylor GM, James VHZ, Walker G (1979) Plasma prednisolone levels and adrenocortical responsiveness after administration of prednisolone-21-phosphate as a retention enema. Gut 20:349–355

    Article  PubMed  CAS  Google Scholar 

  30. Levine DS, Raisys VA, Airnardi V (1987) Coating of oral beclomethasone diproprionate capsules with cellulose acetate phtalate enhances delivery of topically anti inflammatory drug to terminal ileum. Gastroenterology 92:1037–1044

    PubMed  CAS  Google Scholar 

  31. Levinson RA (1986) Intrarectal treatment of ulcerative colitis with tixocortol pivalate. A topical non-systemic anti-inflammatory steroid, comparison with hydrocortisone enema. Gastroenterology 90:1520 (abstract)

    Google Scholar 

  32. Malchow H (1987) Die Behandlung chronisch entzündlicher Darmerkrankungen mit 5-Aminosalizylsäure. Internist 28:14–20

    PubMed  CAS  Google Scholar 

  33. McIntyre PB, Macrae FA, Berghous L, et al. (1985) Therapeutic benefits from a poorly absorbed prednisolone enema in distal colitis. Gut 26:822–824

    Article  PubMed  CAS  Google Scholar 

  34. Rachmilewitz D (1988) Mesalazine/claversal is as effective as sulfasalazine (SZ) in the treatment of active ulcerative colitis. Verh Symposium Gravenbruch 23.–25. März 1988

    Google Scholar 

  35. Rudell WSJ, Dickinson FJ, Rixon MF, et al. (1980) Treatment of distal ulcerative colitis (proctosigmoiditis) in relapse: Comparison of hydrocortisone enemas and rectal hydrocortisone foam. Gut 21:855–889

    Article  Google Scholar 

  36. Rohr G, Kusterer K, Schille M, Gladisch R, Schwedes U, Teuber J, Usadel KH (1987) Treatment of Crohn’s disease and ulcerative colitis with 7-immunglobuline. Lancet II:170 (letter)

    Article  Google Scholar 

  37. Rutgeert P (1988) Mesasal® (5-ASA) is as effective as sulfasalazine (SZ) in maintaining ulcerative colitis (UC) in remission. Verh. Symposium Gravenbruch 23.–25. März 1988

    Google Scholar 

  38. Sachar DB, Rubin KP, Gumaste V (1987) Levamisole in Crohn’s disease: A randomized double-blind, placebo-controlled clinical trial. Am J Gastroenterol 82:536–539

    PubMed  CAS  Google Scholar 

  39. Sandberg-Gertzen H, Järnerot G, Kraaz W (1986) Azodisal sodium in the treatment of ulcerative colitis: A study of relapse-prevention properties. Gastroenterology 90:1024–1030

    PubMed  CAS  Google Scholar 

  40. Sandberg-Gertzen H, Ryde M, Järnerot G (1983) Absorption and excretion of a single 1 g dose of azodisal sodium in subjects with ileostomy. Scand J Gastroenterol 18:107–111

    Article  PubMed  CAS  Google Scholar 

  41. Schroeder KW, Tremaine WJ, Ilstrup DM (1987) Coated oral 5-amino salicylic acid therapy for mildly to moderately active ulcerative colitis. N Engl J Med 317:1625–1629

    Article  PubMed  CAS  Google Scholar 

  42. Selby WS, Bennett MK, Jewell DP (1984) Topical treatment of distal ulcerative colitis with 4-aminosalicylic acid enemas. Digestion 29:231–234

    Article  PubMed  CAS  Google Scholar 

  43. Shaffer JL, Hughes S, Linaher BD, et al. (1984) Controlled trial of rifampicin and ethambutol in Crohn’s disease. Gut 25:203–205

    Article  PubMed  CAS  Google Scholar 

  44. Singe CC, Ewe K (1987) Verändert die Einführung von 5-Aminosalizylsäure (Salofalk®, Claversal®) die medikamentöse Therapie bei chronisch entzündlichen Darmerkrankungen? Ärztebl Rheinland-Pfalz 8:405–408

    Google Scholar 

  45. Somerville KW, Langman MJS, Kane SP, et al. (1985) Effect of distal treatment on symptoms and quality of life in patients with ulcerative colitis: Comparative trial of hydrocortisone acetate foam and prednisolone 21-phosphate enemas. Br Med J 291:866

    Article  CAS  Google Scholar 

  46. Svartz N (1948) The treatment of 124 cases of ulcerative colitis with salazopyrine and attempts of desensitization in cases of hypersensitiveness to sulfa. Acta Med Scand 139 [Suppl 206]:465–472

    Google Scholar 

  47. Thomson ABR (1988) Mesasal/claversal prevents relaps and maintains remission of inactive Crohn’s disease. International mesalacine study group. Verh Symposium Gravenbruch 23.–25. März 1988

    Google Scholar 

  48. Truelove SC (1958) Treatment of ulcerative colitis with local hydrocortisone hemisuccinat sodium: Report on a controlled therapeutic trial. Br Med J 2:1072–1077

    Article  PubMed  CAS  Google Scholar 

  49. Tytgat GNJ, Van der Heide H, Von den Brandt-Gradel, et al. (1985) Comparison of beclomethasone-diproprionate (BDP) and prednisolone 21-phosphate (PP) enemas in distal ulcerative colitis. A double blind study. Gastroenterology 88:1620 (abstract)

    Google Scholar 

  50. Willoughby CP, Heyworth MF, Piris J, et al. (1979) Comparison of disodium cromoglycate and sulfasalazine as maintenance therapy for ulcerative colitis. Lancet I:119–122

    Article  Google Scholar 

  51. Wright JP, Mee AS, Parfitt A, et al. (1985) Vitamin A therapy in patients with Crohn’s disease. Gastroenterology 88:512–514

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. I. Medizinische Klinik, Joh. Gutenberg Universität Mainz, Deutschland

    K. Ewe

Authors
  1. K. Ewe
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Humboldtstr. 14, D-6200, Wiesbaden, Deutschland

    Klaus Miehlke

Rights and permissions

Reprints and permissions

Copyright information

© 1988 J. F. Bergmann Verlag, München

About this paper

Cite this paper

Ewe, K. (1988). Neue Entwicklungen und Tendenzen in der Pharmakotherapie chronisch entzündlicher Darmerkrankungen. In: Miehlke, K. (eds) 94. Kongreß. Verhandlungen der Deutschen Gesellschaft für Innere Medizin, vol 94. J.F. Bergmann-Verlag. https://doi.org/10.1007/978-3-642-85461-3_33

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-85461-3_33

  • Publisher Name: J.F. Bergmann-Verlag

  • Print ISBN: 978-3-8070-0376-4

  • Online ISBN: 978-3-642-85461-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation